Gorgojo-Martinez, J.J.; Brito-Sanfiel, M.; Antón-Bravo, T.; Galdón Sanz-Pastor, A.; Wong-Cruz, J.; Gargallo Fernández, M.A.
Predictive Factors of Renal Function Decline in Patients with Type 2 Diabetes Treated with Canagliflozin in the Real-Wecan Study. J. Clin. Med. 2022, 11, 5622.
https://doi.org/10.3390/jcm11195622
AMA Style
Gorgojo-Martinez JJ, Brito-Sanfiel M, Antón-Bravo T, Galdón Sanz-Pastor A, Wong-Cruz J, Gargallo Fernández MA.
Predictive Factors of Renal Function Decline in Patients with Type 2 Diabetes Treated with Canagliflozin in the Real-Wecan Study. Journal of Clinical Medicine. 2022; 11(19):5622.
https://doi.org/10.3390/jcm11195622
Chicago/Turabian Style
Gorgojo-Martinez, Juan J., Miguel Brito-Sanfiel, Teresa Antón-Bravo, Alba Galdón Sanz-Pastor, Jaime Wong-Cruz, and Manuel A. Gargallo Fernández.
2022. "Predictive Factors of Renal Function Decline in Patients with Type 2 Diabetes Treated with Canagliflozin in the Real-Wecan Study" Journal of Clinical Medicine 11, no. 19: 5622.
https://doi.org/10.3390/jcm11195622
APA Style
Gorgojo-Martinez, J. J., Brito-Sanfiel, M., Antón-Bravo, T., Galdón Sanz-Pastor, A., Wong-Cruz, J., & Gargallo Fernández, M. A.
(2022). Predictive Factors of Renal Function Decline in Patients with Type 2 Diabetes Treated with Canagliflozin in the Real-Wecan Study. Journal of Clinical Medicine, 11(19), 5622.
https://doi.org/10.3390/jcm11195622
